Corona Virus Illness-2019 (COVID-19) has unfold extensively all through the world for the reason that finish of 2019. Nucleic acid testing (NAT) has performed an essential function in affected person analysis and administration of COVID-19. In some circumstances, thermal inactivation at 56 °C has been beneficial to inactivate Extreme Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) earlier than NAT. Nevertheless, this process might theoretically disrupt nucleic acid integrity of this single-stranded RNA virus and trigger false negatives in real-time polymerase chain response (RT–PCR) assessments.
We investigated whether or not thermal inactivation might have an effect on the outcomes of viral NAT. We examined the consequences of thermal inactivation on the quantitative RT–PCR outcomes of SARS-CoV-2 significantly with regard to the charges of false-negative outcomes for specimens carrying low viral masses. We moreover investigated the consequences of various specimen sorts, pattern preservation occasions and a chemical inactivation strategy on NAT.Our work confirmed elevated Ct values in specimens from identified COVID-19 sufferers in RT–PCR assessments after thermal incubation.
Furthermore, about half of the weak-positive samples (7 of 15 samples, 46.7%) had been RT–PCR destructive after warmth inactivation in a minimum of one parallel testing. The usage of guanidinium-based lysis for preservation of those specimens had a smaller influence on RT–PCR outcomes with fewer false negatives (2 of 15 samples, 13.3%) and considerably much less enhance in Ct values than warmth inactivation.Thermal inactivation adversely affected the effectivity of RT–PCR for SARS-CoV-2 detection. Given the restricted applicability related to chemical inactivators, different approaches to make sure the general safety of laboratory personnel want consideration.
A novel pure antisense transcript at human SOX9 locus is down-regulated in most cancers and stem cells.
SOX9 is a key transcription issue with essential roles in regulating proliferation and differentiation of varied cell sorts. Dysregulation of SOX9 expression has been concerned with pathogenesis of various developmental, degenerative, and neoplastic issues. Pure antisense transcripts (NATs) are lengthy non-coding RNAs with rising significance in regulation of gene expression. Nevertheless, the presence of a NAT at SOX9 locus has been to date unclear.We detected a pure antisense transcript at SOX9 locus (SOX9-NAT) by means of strand-specific RT–PCR.
In distinction to SOX9 sense RNA (mRNA), SOX9-NAT was down-regulated in most cancers tissues and cell strains in contrast with their regular counterparts. As well as, reciprocal to SOX9 mRNA, SOX9-NAT was additionally down-regulated in human embryonic stem cells compared with human fibroblasts in vitro.The destructive correlation between SOX9 mRNA and SOX9-NAT was confirmed by analyzing qPCR knowledge, in addition to RNA-Seq datasets of a number of human cancers. Our knowledge recommend a practical function for SOX9-NAT within the regulation of SOX9 mRNA as a possible goal in most cancers remedy and regenerative drugs.
Hepatitis B viral an infection has been transmitted from donors with HBV infections who’ve destructive HBs Ag. Many international locations have applied nucleic acid testing (NAT) to display screen donors with non- reactive HBs Ag for detection of HBV DNA and improve security of blood transfusion, whereas it’s restricted to restricted blood banks in Egypt.To guage the importance of NAT know-how in detection of HBV DNA within the Egyptian blood donors with HBs Ag non- reactivity.The research included 36,584 collected blood samples from volunteer blood donors on the blood financial institution of Zagazig College Hospitals.
Every specimen was examined for HBs Ag; non- reactive sera had been additional examined for qualitative detection of HBV-DNA by NAT testing. All optimistic HBV-DNA donors had been examined for anti- HBc and anti- HBs by electro-chemiluminescence immunoassay and confirmed by quantitative RT–PCR.Amongst 34,671 donors non-reactive to HBs Ag, 34,657 (99.96%) had been examined destructive for HBV- DNA and 14 specimens (0.04%) had been optimistic for HBV through NAT testing.
Amongst HBV NAT optimistic donors, HBs Ab reactive solely in (2); HBc Ab reactive solely in (3); HBs and HBc Abs reactive in (3) whereas HBs and HBc Ab non-reactive in (6). All examined sera 14 (100%) confirmed low viral load for HBV (<50 IU/ml) confirmed by RT– qPCR.Our outcomes highlighted the importance of the HBV NAT method to scale back the potential threat of HBV transfusion-transmission and the important have to implement the utilization of NAT know-how in all blood banks in Egypt.
Rumen-Protected 5-Hydroxytryptophan Improves Sheep Melatonin Synthesis within the Pineal Gland and Intestinal Tract.
Primarily based on the in depth organic results of melatonin (MLT), it’s helpful to extend the MLT content material within the our bodies of animals at a selected physiological stage. This research was carried out to research the impact of a weight loss program supplemented with rumen-protected (RP) 5-hydroxytryptophan (5-HTP) on the pineal gland and intestinal tract MLT synthesis of sheep. Eighteen Kazakh sheep had been assigned randomly to three weight loss program teams: management group (CT, corn-soybean meal basal weight loss program), CT+111 group, and CT+222 group.
The gene expressions of fragrant amino acid decarboxylase (AADC), arylalkylamine N-acetyltransferase (AA-NAT), hydroxyindole-O-methyltransferase (HIOMT), monoamine oxidase A (MAOA), and the intermediates of MLT synthesis had been noticed from the pineal gland and intestinal tract by the reverse transcription (RT)-PCR methodology. The 5-HTP, 5-HT, N-acetylserotonin, MLT, and 5-hydroxyindole acetic acid (5-HIAA) contents within the pineal gland and intestinal tract had been analyzed by ultra-high-performance liquid chromatography-tandem mass spectrometry. RESULTS The research confirmed that the pineal gland HIOMT expression (P<0.05)
E. coli RecA Protein |
|||
01-001 | Sceti | 200 ug | EUR 246 |
Description: The E. coli RecA Protein is available in Europe and for worldwide shipping via Gentaur. |
E. coli RuvA protein |
|||
01-007 | Sceti | 50 ug | EUR 574.8 |
Description: The E. coli RuvA protein is available in Europe and for worldwide shipping via Gentaur. |
E. coli RuvA protein |
|||
01-008 | Sceti | 250 ug | EUR 1420.8 |
Description: The E. coli RuvA protein is available in Europe and for worldwide shipping via Gentaur. |
E. coli RuvB protein |
|||
01-009 | Sceti | 50 ug | EUR 574.8 |
Description: The E. coli RuvB protein is available in Europe and for worldwide shipping via Gentaur. |
E. coli RuvB protein |
|||
01-010 | Sceti | 250 ug | EUR 1420.8 |
Description: The E. coli RuvB protein is available in Europe and for worldwide shipping via Gentaur. |
E. coli RuvC protein |
|||
01-011 | Sceti | 50 ug | EUR 574.8 |
Description: The E. coli RuvC protein is available in Europe and for worldwide shipping via Gentaur. |
E. coli RuvC protein |
|||
01-012 | Sceti | 250 ug | EUR 1420.8 |
Description: The E. coli RuvC protein is available in Europe and for worldwide shipping via Gentaur. |
RecA Protein E. coli |
|||
M1231-200 | Biovision | EUR 242.4 |
Escherichia coli (E. coli) Antibody |
|||
abx415692-01mg | Abbexa | 0.1 mg | EUR 760.8 |
Escherichia coli (E. coli) Antibody |
|||
abx415712-1ml | Abbexa | 1 ml | EUR 727.2 |
Escherichia coli (E. coli) Antibody |
|||
abx411320-1ml | Abbexa | 1 ml | EUR 610.8 |
E. coli GroL |
|||
DAG1704 | Creative Diagnostics | 100 ug | EUR 1098 |
E. coli GroS |
|||
DAG1705 | Creative Diagnostics | 100 ug | EUR 1098 |
E. coli DsbA |
|||
DAG1712 | Creative Diagnostics | 100 ug | EUR 1098 |
E. coli GrpE |
|||
DAG1714 | Creative Diagnostics | 100 ug | EUR 1232.4 |
E. coli antibody |
|||
20-ER13 | Fitzgerald | 1 ml | EUR 426 |
Description: Rabbit polyclonal E. coli antibody |
E. coli antibody |
|||
20C-CR1244GP | Fitzgerald | 1 ml | EUR 561.6 |
Description: Goat polyclonal E. coli antibody |
E. coli antibody |
|||
10C-CR1244M1 | Fitzgerald | 100 ug | EUR 489.6 |
Description: Mouse monoclonal E. coli antibody |
E. coli antibody |
|||
10-E09C | Fitzgerald | 100 ug | EUR 159.6 |
Description: Mouse monoclonal E. coli antibody |
E. coli antibody |
|||
10-E10A | Fitzgerald | 500 ug | EUR 591.6 |
Description: Mouse monoclonal E. coli antibody |
E. coli antibody |
|||
10-E10B | Fitzgerald | 500 ug | EUR 591.6 |
Description: Mouse monoclonal E. coli antibody |
E. coli Antibody |
|||
abx021669-1mg | Abbexa | 1 mg | EUR 1554 |
E. coli Antibody |
|||
abx021670-1mg | Abbexa | 1 mg | EUR 1045.2 |
E. coli Antibody |
|||
abx021671-02ml | Abbexa | 0.2 ml | EUR 594 |
E. coli Antibody |
|||
abx021672-1mg | Abbexa | 1 mg | EUR 1045.2 |
E. coli Antibody |
|||
abx021673-1mg | Abbexa | 1 mg | EUR 1045.2 |
E. coli Antibody |
|||
abx022970-1ml | Abbexa | 1 ml | EUR 878.4 |
E. coli Antibody |
|||
abx022971-1ml | Abbexa | 1 ml | EUR 1161.6 |
E. coli Antibody |
|||
abx022975-1ml | Abbexa | 1 ml | EUR 718.8 |
E. coli Antibody |
|||
abx022977-1ml | Abbexa | 1 ml | EUR 811.2 |
Recombinant (E. coli) Yellow Fluorescent Proteins (YFP) protein for ELISA or Standards (>98%) |
|||
YFP15-R | Alpha Diagnostics | 25 ug | EUR 300 |
E. Coli O 157 Protein |
|||
abx061475-01ml | Abbexa | 0.1 ml | EUR 661.2 |
Escherichia coli (E. coli) Antibody (Biotin) |
|||
abx415713-1ml | Abbexa | 1 ml | EUR 861.6 |
Escherichia coli (E. coli) Antibody (Biotin) |
|||
abx411321-1ml | Abbexa | 1 ml | EUR 710.4 |
Escherichia coli (E. coli) Antibody (FITC) |
|||
abx411322-1ml | Abbexa | 1 ml | EUR 610.8 |
Recombinant (E. coli) Red Fluorescent Proteins (RFP/dsRed) protein for ELISA or Standards (>98%) |
|||
RFP15-R | Alpha Diagnostics | 25 ug | EUR 300 |
E. coli Protein GrpE (GrpE) Protein |
|||
20-abx261718 | Abbexa |
|
|
E. coli FimC [His] |
|||
DAG1666 | Creative Diagnostics | 100 ug | EUR 1232.4 |
E. coli Eco [His] |
|||
DAG1667 | Creative Diagnostics | 50 ug | EUR 1232.4 |
E. Coli Recombinant TRXB |
|||
6331-100 | Biovision | EUR 510 |
E. Coli Recombinant SlyD |
|||
6366-100 | Biovision | EUR 548.4 |
E. coli DnaJ Antibody |
|||
32022-05111 | AssayPro | 150 ug | EUR 313.2 |
E. coli pykF Antibody |
|||
32163-05111 | AssayPro | 150 ug | EUR 313.2 |
E. coli GOR Antibody |
|||
32540-05111 | AssayPro | 150 ug | EUR 313.2 |
E. coli NDK Antibody |
|||
32662-05111 | AssayPro | 150 ug | EUR 313.2 |
E. coli PPA Antibody |
|||
32678-05111 | AssayPro | 150 ug | EUR 313.2 |
E. coli antibody (FITC) |
|||
60-E13 | Fitzgerald | 1 ml | EUR 453.6 |
Description: Rabbit polyclonal E. coli antibody (FITC) conjugated |
E. coli antibody (biotin) |
|||
60-E13B | Fitzgerald | 1 ml | EUR 561.6 |
Description: Rabbit polyclonal E. coli antibody (biotin) conjugated |
E. coli antibody (HRP) |
|||
60-E14 | Fitzgerald | 1 ml | EUR 489.6 |
Description: Rabbit polyclonal E. coli antibody (HRP) conjugated |
E. Coli HCP antibody |
|||
20R-EG001 | Fitzgerald | 1 ml | EUR 1004.4 |
Description: Goat polyclonal E. Coli HCP antibody |
E. coli GroEL Antibody |
|||
20012-05011 | AssayPro | 150 ug | EUR 260.4 |
E. coli O157 antibody |
|||
10C-CR1295M3 | Fitzgerald | 100 ug | EUR 470.4 |
Description: Mouse monoclonal E. coli O157 antibody |
E. coli CysH Antibody |
|||
30281-05111 | AssayPro | 150 ug | EUR 313.2 |
E. coli glk Antibody |
|||
32864-05111 | AssayPro | 150 ug | EUR 313.2 |
E. Coli ldhA Antibody |
|||
32898-05111 | AssayPro | 150 ug | EUR 313.2 |
E. coli deoC Antibody |
|||
32936-05111 | AssayPro | 150 ug | EUR 313.2 |
E. coli Skp Antibody |
|||
32971-05111 | AssayPro | 150 ug | EUR 313.2 |
E. coli nanA Antibody |
|||
33092-05111 | AssayPro | 150 ug | EUR 313.2 |
E. coli LexA repressor |
|||
01-005 | Sceti | 50 ug | EUR 574.8 |
Description: The E. coli LexA repressor is available in Europe and for worldwide shipping via Gentaur. |
E. coli LexA repressor |
|||
01-006 | Sceti | 250 ug | EUR 1420.8 |
Description: The E. coli LexA repressor is available in Europe and for worldwide shipping via Gentaur. |
TesA, E. coli esterase |
|||
0306-1 | AthenaES | 100 Units | EUR 505.2 |
TesA, E. coli esterase |
|||
0306-5 | AthenaES | 500 Units | EUR 2046 |
E. coli O157 antibody |
|||
10-1490 | Fitzgerald | 100 ug | EUR 163.2 |
Description: Mouse monoclonal E. coli O157 antibody |
E. coli O157 antibody |
|||
10-1521 | Fitzgerald | 100 ug | EUR 170.4 |
Description: Mouse monoclonal E. coli O157 antibody |
E. coli O157 antibody |
|||
10-E12A | Fitzgerald | 100 ug | EUR 462 |
Description: Mouse monoclonal E. coli O157 antibody |
E. coli O157 Antibody |
|||
abx021684-1mg | Abbexa | 1 mg | EUR 1220.4 |
E. coli O157 Antibody |
|||
abx021685-1mg | Abbexa | 1 mg | EUR 1195.2 |
E. coli O157 Antibody |
|||
abx021686-1mg | Abbexa | 1 mg | EUR 1195.2 |
E. coli O157 Antibody |
|||
abx021687-1mg | Abbexa | 1 mg | EUR 1195.2 |
E. coli O157 Antibody |
|||
abx021688-1mg | Abbexa | 1 mg | EUR 1128 |
E. coli O157 Antibody |
|||
abx021689-1mg | Abbexa | 1 mg | EUR 1195.2 |
E. coli Antibody (HRP) |
|||
abx022972-1ml | Abbexa | 1 ml | EUR 718.8 |
E. coli Antibody (FITC) |
|||
abx022974-1ml | Abbexa | 1 ml | EUR 777.6 |
E. coli Antibody (Biotin) |
|||
abx022976-1ml | Abbexa | 1 ml | EUR 718.8 |
E. coli Antibody (HRP) |
|||
abx022978-1ml | Abbexa | 1 ml | EUR 1053.6 |
E. coli Antibody (Biotin) |
|||
abx022979-1ml | Abbexa | 1 ml | EUR 886.8 |
E. coli O157 Antibody |
|||
abx024017-1mg | Abbexa | 1 mg | EUR 1212 |
E. coli O 157 |
|||
abx291002-100mg | Abbexa | 100 mg | EUR 744 |
Benzonase, E. Coli Recombinant |
|||
7680-25 | Biovision | EUR 398.4 |
Benzonase, E. Coli Recombinant |
|||
7680-5 | Biovision | EUR 164.4 |
E. coli DNA Ligase |
|||
M1217-100 | Biovision | EUR 385.2 |
E. coli Exonuclease I |
|||
M1222-100 | Biovision | EUR 301.2 |
E. coli Exonuclease III |
|||
M1223-100 | Biovision | EUR 320.4 |
E. coli Recombinant IDNK |
|||
P1050-10 | Biovision | EUR 196.8 |
E. coli Recombinant IDNK |
|||
P1050-50 | Biovision | EUR 457.2 |
Recombinant E. coli, Glucokinase |
|||
P1054-10 | Biovision | EUR 196.8 |
Recombinant E. coli, Glucokinase |
|||
P1054-50 | Biovision | EUR 457.2 |
Enterotoxin STp (E. coli) |
|||
H-6248.0500 | Bachem | 0.5mg | EUR 835.2 |
Description: Sum Formula: C81H110N20O26S6; CAS# [115474-04-9] net |
Enterotoxin STp (E. coli) |
|||
H-6248.1000 | Bachem | 1.0mg | EUR 1416 |
Description: Sum Formula: C81H110N20O26S6; CAS# [115474-04-9] net |
E. coli Topoisomerase IV |
|||
TG2000EC-1 | TopoGen | 250 units | EUR 537.6 |
E. coli Topoisomerase IV |
|||
TG2000EC-3 | TopoGen | 500 units | EUR 819.6 |
E. coli Topoisomerase IV |
|||
TG2000EC-5 | TopoGen | 1000 units | EUR 1262.4 |
E. coli DNA Gyrase |
|||
TG2000G-1 | TopoGen | 100 units | EUR 388.8 |
E. coli DNA Gyrase |
|||
TG2000G-3 | TopoGen | 500 units | EUR 846 |
E. coli DNA Gyrase |
|||
TG2000G-5 | TopoGen | 1000 units | EUR 1396.8 |
E. coli DNA Gyrase |
|||
TG2000G-7 | TopoGen | 2000 units | EUR 2203.2 |
E. coli O157 Antibody |
|||
V3307-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
Description: This mAb shows specificity to E. coli O157 in a simple ELISA. Escherichia coli are Gram negative bacterium that are commonly found in the lower intestine of warm-blooded organisms (endotherms). Their serological types are determined in combination with somatic antigens (O group: O1-O173) and flagella antigens (H type: H1-H56). The E. coli that cause intestinal infectious diseases including diarrhea, acute gastritis or colitis are referred to as pathogenic E. coli, which are classified into the following four groups according to differences in the mode of pathogenicity; enteropathogenic E. coli (EPEC), enteroinvasive E. coli (EIEC), enterotoxigenic E. coli (ETEC) and enterohemorrhagic E. coli (EHEC). Although the identification of pathogenic E. coli requires verification of their pathogenicity, pathogenic E. coli often have specific serotypes; therefore, typing of the serogroup and serotype is necessary in screening pathogenic E. coli. |
E. coli O157 Antibody |
|||
V3307-20UG | NSJ Bioreagents | 20 ug | EUR 219 |
Description: This mAb shows specificity to E. coli O157 in a simple ELISA. Escherichia coli are Gram negative bacterium that are commonly found in the lower intestine of warm-blooded organisms (endotherms). Their serological types are determined in combination with somatic antigens (O group: O1-O173) and flagella antigens (H type: H1-H56). The E. coli that cause intestinal infectious diseases including diarrhea, acute gastritis or colitis are referred to as pathogenic E. coli, which are classified into the following four groups according to differences in the mode of pathogenicity; enteropathogenic E. coli (EPEC), enteroinvasive E. coli (EIEC), enterotoxigenic E. coli (ETEC) and enterohemorrhagic E. coli (EHEC). Although the identification of pathogenic E. coli requires verification of their pathogenicity, pathogenic E. coli often have specific serotypes; therefore, typing of the serogroup and serotype is necessary in screening pathogenic E. coli. |
E. coli O157 Antibody |
|||
V3307SAF-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
Description: This mAb shows specificity to E. coli O157 in a simple ELISA. Escherichia coli are Gram negative bacterium that are commonly found in the lower intestine of warm-blooded organisms (endotherms). Their serological types are determined in combination with somatic antigens (O group: O1-O173) and flagella antigens (H type: H1-H56). The E. coli that cause intestinal infectious diseases including diarrhea, acute gastritis or colitis are referred to as pathogenic E. coli, which are classified into the following four groups according to differences in the mode of pathogenicity; enteropathogenic E. coli (EPEC), enteroinvasive E. coli (EIEC), enterotoxigenic E. coli (ETEC) and enterohemorrhagic E. coli (EHEC). Although the identification of pathogenic E. coli requires verification of their pathogenicity, pathogenic E. coli often have specific serotypes; therefore, typing of the serogroup and serotype is necessary in screening pathogenic E. coli. |
Human Escherichia coli (E. coli) ELISA Kit |
|||
abx052493-96tests | Abbexa | 96 tests | EUR 801.6 |
Cow Escherichia coli (E. coli) ELISA Kit |
|||
abx055785-96tests | Abbexa | 96 tests | EUR 801.6 |
E. coli 0157:H7 cell protein |
|||
30-AE13 | Fitzgerald | 1 ml | EUR 340.8 |
Description: Heat inactivated E. coli O157:H7 cells |
E. coli Syndecan 1 (SDC1) Protein |
|||
20-abx263542 | Abbexa |
|
|
E. coli Progesterone Receptor (PGR) Protein |
|||
20-abx263552 | Abbexa |
|
|
Recombinant Human RAGE Protein (E. coli) |
|||
VAng-2906Lsx-1mg | Creative Biolabs | 1 mg | EUR 4316.4 |
Description: Recombinant Human RAGE (AGER) protein is expressed in E. coli. (Uniprot ID: Q15109) |
Recombinant Human RAGE Protein (E. coli) |
|||
VAng-2906Lsx-200g | Creative Biolabs | 200 µg | EUR 1594.8 |
Description: Recombinant Human RAGE (AGER) protein is expressed in E. coli. (Uniprot ID: Q15109) |
Recombinant Human RAGE Protein (E. coli) |
|||
VAng-2906Lsx-500g | Creative Biolabs | 500 µg | EUR 2749.2 |
Description: Recombinant Human RAGE (AGER) protein is expressed in E. coli. (Uniprot ID: Q15109) |
Recombinant CMV Protein (E. coli) [GST] |
|||
VAng-Lsx0035-inquire | Creative Biolabs | inquire | Ask for price |
Description: CMV [GST], recombinant protein from E. coli. |
Recombinant Trypanosoma Cruiz Protein (E. coli) |
|||
VAng-Wyb8373-1mg | Creative Biolabs | 1 mg | EUR 4431.6 |
Description: Trypanosoma Cruiz protein, recombinant protein. |
Recombinant HIV-2 E gp 36 Protein (E. coli) |
|||
VAng-0534Lsx-inquire | Creative Biolabs | inquire | Ask for price |
Description: HIV type 2 Envelope glycoprotein 36, recombinant protein from E. coli. MW 16 kDa, 1 mg/mL. |
Cytochalasin E |
|||
C197-1MG | TOKU-E | 1 mg | EUR 157.2 |
Cytochalasin E |
|||
C197-5MG | TOKU-E | 5 mg | EUR 462 |
Deoxybrevianamide E |
|||
D083-1MG | TOKU-E | 1 mg | EUR 333.6 |
Deoxybrevianamide E |
|||
D083-5MG | TOKU-E | 5 mg | EUR 1076.4 |
Oligomycin E |
|||
O021-1MG | TOKU-E | 1 mg | EUR 381.6 |
Oligomycin E |
|||
O021-5MG | TOKU-E | 5 mg | EUR 1248 |
Paraherquamide E |
|||
P070-0.5MG | TOKU-E | 0.5 mg | EUR 480 |
Paraherquamide E |
|||
P070-2.5MG | TOKU-E | 2.5 mg | EUR 1590 |
Phenelfamycin E |
|||
P078-1MG | TOKU-E | 1 mg | EUR 381.6 |
Phenelfamycin E |
|||
P078-5MG | TOKU-E | 5 mg | EUR 1248 |
Roquefortine E |
|||
R035-1MG | TOKU-E | 1 mg | EUR 268.8 |
Roquefortine E |
|||
R035-5MG | TOKU-E | 5 mg | EUR 849.6 |
E. coli Chaperone Protein Dnaj (DNAJ) Protein |
|||
20-abx260479 | Abbexa |
|
|
E. coli Chaperone Protein SKP (SKP) Protein |
|||
20-abx260554 | Abbexa |
|
|
E. coli Green Fluorescent Protein (GFP) Protein |
|||
20-abx260632 | Abbexa |
|
|
Purified Rec. E. Coli Thioredoxin (TrxA, E. coli) (fusion protein) for WB +ve control |
|||
THRX11-C | Alpha Diagnostics | 100 ul | EUR 343.2 |
E. coli DNA Primase Assay Kit Plus (E. coli primase-helicase included) |
|||
EGA100KE | ProFoldin | 100 assays | EUR 444.91 |
Description: This product includes all the kit components in E. coli DNA Primase Assay Kit (Catalog No. EGA100K ) plus 45 ul of 100 x E. coli primase-helicase complex. It is for 100 assays of E.coli DNA primase reactions in a 96-well plate format or 200 assays in 384-well assay format. |
E. coli RNA polymerase Assay Kit Plus (E. coli RNA polymerase included) |
|||
RPA100KE | ProFoldin | 100 assays | EUR 467.15 |
Description: This product includes all the reagents in E. coli RNA Polymerase Assay Kit (Catalog number RPA100K) plus the enzyme, 33 ul of 100 x E. coli RNAP. It is for 100 assays of E. coli RNA polymerase reactions in a 384-well assay format. |
Escherichia coli Serotype O2 (E. coli O2) Antibody |
|||
abx411330-02mg | Abbexa | 0.2 mg | EUR 678 |
Escherichia coli Serotype O15 (E. coli O15) Antibody |
|||
abx411331-02mg | Abbexa | 0.2 mg | EUR 678 |
Escherichia coli Serotype O20 (E. coli O20) Antibody |
|||
abx411332-02mg | Abbexa | 0.2 mg | EUR 678 |
E. coli O157 (9.88) Antibody |
|||
BNCA0207-250 | Biotium | 250uL | EUR 459.6 |
Description: Primary antibody against E. coli O157 (9.88),APC conjugate, Concentration: 0.1mg/mL |
E. coli O157 (9.88) Antibody |
|||
BNCAP0207-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against E. coli O157 (9.88),Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
E. coli O157 (9.88) Antibody |
|||
BNCAP0207-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against E. coli O157 (9.88),Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
E. coli β-gal peptide |
|||
DAG2441 | Creative Diagnostics | 0.05 mg | EUR 582 |
Native E. Coli O 158 |
|||
DAGA-3025 | Creative Diagnostics | 0.1 ml | EUR 858 |
Uricase from E. coli, Recombinant |
|||
DIA-415 | Creative Enzymes | 5KU | EUR 453.6 |
E. coli O157 (9.88) Antibody |
|||
BNC610207-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against E. coli O157 (9.88),CF660R conjugate, Concentration: 0.1mg/mL |
E. coli O157 (9.88) Antibody |
|||
BNC610207-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against E. coli O157 (9.88),CF660R conjugate, Concentration: 0.1mg/mL |
E. coli O157 (9.88) Antibody |
|||
BNC680207-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against E. coli O157 (9.88),CF568 conjugate, Concentration: 0.1mg/mL |
E. coli O157 (9.88) Antibody |
|||
BNC680207-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against E. coli O157 (9.88),CF568 conjugate, Concentration: 0.1mg/mL |
E. coli O157 (9.88) Antibody |
|||
BNCR0207-250 | Biotium | 250uL | EUR 459.6 |
Description: Primary antibody against E. coli O157 (9.88),RPE conjugate, Concentration: 0.1mg/mL |
E. coli O157 (9.88) Antibody |
|||
BNUB0207-100 | Biotium | 100uL | EUR 250.8 |
Description: Primary antibody against E. coli O157 (9.88), Concentration: 0.2mg/mL |
E. coli O157 (9.88) Antibody |
|||
BNUB0207-500 | Biotium | 500uL | EUR 549.6 |
Description: Primary antibody against E. coli O157 (9.88), Concentration: 0.2mg/mL |
E. coli O157 (9.88) Antibody |
|||
BNC430207-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against E. coli O157 (9.88),CF543 conjugate, Concentration: 0.1mg/mL |
E. coli O157 (9.88) Antibody |
|||
BNC430207-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against E. coli O157 (9.88),CF543 conjugate, Concentration: 0.1mg/mL |
E. coli O157 (9.88) Antibody |
|||
BNC470207-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against E. coli O157 (9.88),CF647 conjugate, Concentration: 0.1mg/mL |
E. coli O157 (9.88) Antibody |
|||
BNC470207-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against E. coli O157 (9.88),CF647 conjugate, Concentration: 0.1mg/mL |
rHu BMP-2 (E. coli) |
|||
AK8356-0002 | Akron Biotech | 2µg | Ask for price |
rHu BMP-2 (E. coli) |
|||
AK8356-0010 | Akron Biotech | 10µg | Ask for price |
rHu BMP-2 (E. coli) |
|||
AK8356-0100 | Akron Biotech | 100µg | Ask for price |
rHu BMP-2 (E. coli) |
|||
AK8356-1000 | Akron Biotech | 1mg | Ask for price |
E. coli O157 (9.88) Antibody |
|||
BNC400207-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against E. coli O157 (9.88),CF640R conjugate, Concentration: 0.1mg/mL |
E. coli O157 (9.88) Antibody |
|||
BNC400207-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against E. coli O157 (9.88),CF640R conjugate, Concentration: 0.1mg/mL |
E. coli O157 (9.88) Antibody |
|||
BNC880207-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against E. coli O157 (9.88),CF488A conjugate, Concentration: 0.1mg/mL |
E. coli O157 (9.88) Antibody |
|||
BNC880207-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against E. coli O157 (9.88),CF488A conjugate, Concentration: 0.1mg/mL |
E. coli O157 (9.88) Antibody |
|||
BNC810207-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against E. coli O157 (9.88),CF680R conjugate, Concentration: 0.1mg/mL |
E. coli O157 (9.88) Antibody |
|||
BNC810207-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against E. coli O157 (9.88),CF680R conjugate, Concentration: 0.1mg/mL |
E. coli O157 (9.88) Antibody |
|||
BNCP0207-250 | Biotium | 250uL | EUR 459.6 |
Description: Primary antibody against E. coli O157 (9.88),PerCP conjugate, Concentration: 0.1mg/mL |
E. coli O157 (9.88) Antibody |
|||
BNUM0207-50 | Biotium | 50uL | EUR 474 |
Description: Primary antibody against E. coli O157 (9.88), 1mg/mL |
E. coli O157 (9.88) Antibody |
|||
BNC050207-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against E. coli O157 (9.88),CF405M conjugate, Concentration: 0.1mg/mL |
E. coli O157 (9.88) Antibody |
|||
BNC050207-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against E. coli O157 (9.88),CF405M conjugate, Concentration: 0.1mg/mL |
E. coli O157 (9.88) Antibody |
|||
BNC700207-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against E. coli O157 (9.88),CF770 conjugate, Concentration: 0.1mg/mL |
E. coli O157 (9.88) Antibody |
|||
BNC700207-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against E. coli O157 (9.88),CF770 conjugate, Concentration: 0.1mg/mL |
E. coli O157 (9.88) Antibody |
|||
BNC800207-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against E. coli O157 (9.88),CF680 conjugate, Concentration: 0.1mg/mL |
E. coli O157 (9.88) Antibody |
|||
BNC800207-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against E. coli O157 (9.88),CF680 conjugate, Concentration: 0.1mg/mL |
E. coli O157 (9.88) Antibody |
|||
BNCB0207-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against E. coli O157 (9.88),Biotin conjugate, Concentration: 0.1mg/mL |
E. coli O157 (9.88) Antibody |
|||
BNCB0207-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against E. coli O157 (9.88),Biotin conjugate, Concentration: 0.1mg/mL |
E. coli O157 (9.88) Antibody |
|||
BNC940207-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against E. coli O157 (9.88),CF594 conjugate, Concentration: 0.1mg/mL |
E. coli O157 (9.88) Antibody |
|||
BNC940207-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against E. coli O157 (9.88),CF594 conjugate, Concentration: 0.1mg/mL |
E. coli O157 (9.88) Antibody |
|||
BNC550207-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against E. coli O157 (9.88),CF555 conjugate, Concentration: 0.1mg/mL |
E. coli O157 (9.88) Antibody |
|||
BNC550207-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against E. coli O157 (9.88),CF555 conjugate, Concentration: 0.1mg/mL |
E. coli O157 (9.88) Antibody |
|||
BNCH0207-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against E. coli O157 (9.88),Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
E. coli O157 (9.88) Antibody |
|||
BNCH0207-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against E. coli O157 (9.88),Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
E. Coli Recombinant Thioredoxin 1 |
|||
6329-50 | Biovision | EUR 483.6 |
Insulin, human recombinant (E. coli) |
|||
4772-25 | Biovision | EUR 542.4 |
Insulin, human recombinant (E. coli) |
|||
4772-5 | Biovision | EUR 248.4 |
E. coli Glycerol Kinase Antibody |
|||
32699-05111 | AssayPro | 150 ug | EUR 313.2 |
E. coli O157 antibody (FITC) |
|||
61C-CR1295M1F | Fitzgerald | 100 ug | EUR 489.6 |
Description: Mouse monoclonal E. coli O157 antibody (FITC) |
E. coli O157 antibody (FITC) |
|||
61C-CR1295M4F | Fitzgerald | 100 ug | EUR 561.6 |
Description: Mouse monoclonal E. coli O157 antibody (FITC) |
E. coli O157:H7 antibody |
|||
70-XG13 | Fitzgerald | 1 mg | EUR 734.4 |
Description: Affinity purified Goat polyclonal E. coli O157:H7 antibody. |
E. coli Tryptophanase (Tnase) Antibody |
|||
33517-05111 | AssayPro | 150 ug | EUR 313.2 |
E. coli RecQ DNA helicase |
|||
01-003 | Sceti | 50 ug | EUR 574.8 |
Description: The E. coli RecQ DNA helicase is available in Europe and for worldwide shipping via Gentaur. |
E. coli RecQ DNA helicase |
|||
01-004 | Sceti | 250? g | EUR 1858.8 |
Description: The E. coli RecQ DNA helicase is available in Europe and for worldwide shipping via Gentaur. |
E. coli antibody (K99 Pilus) |
|||
10-E20A | Fitzgerald | 500 ug | EUR 591.6 |
Description: Mouse monoclonal E. coli antibody (K99 Pilus) |
Mouse antibody for E. coli |
|||
1063 | Virostat | 100 ug | EUR 438.46 |
Description: This is Mouse monoclonal FITC conjugated antibody against E coli O157 for WB, ELISA. |
E. coli Enterotoxin B Antibody |
|||
abx021678-1mg | Abbexa | 1 mg | EUR 718.8 |
E. coli Enterotoxin B Antibody |
|||
abx021679-1mg | Abbexa | 1 mg | EUR 727.2 |
E. coli Enterotoxin B Antibody |
|||
abx021680-1mg | Abbexa | 1 mg | EUR 718.8 |
E. coli O157 Antibody (FITC) |
|||
abx021683-1mg | Abbexa | 1 mg | EUR 2798.4 |
E. coli O157:H7 Antibody |
|||
abx022980-1mg | Abbexa | 1 mg | EUR 718.8 |
E. coli Enterotoxin LT Antibody |
|||
abx023834-1mg | Abbexa | 1 mg | EUR 878.4 |
E. coli Enterotoxin LT Antibody |
|||
abx023835-1mg | Abbexa | 1 mg | EUR 878.4 |
E. coli Enterotoxin LT Antibody |
|||
abx023836-1mg | Abbexa | 1 mg | EUR 878.4 |
E. coli Enterotoxin LT Antibody |
|||
abx023837-1mg | Abbexa | 1 mg | EUR 878.4 |
E. coli Enterotoxin STp Antibody |
|||
abx023838-1mg | Abbexa | 1 mg | EUR 1053.6 |
E. coli Enterotoxin STp Antibody |
|||
abx023839-1mg | Abbexa | 1 mg | EUR 1053.6 |
E. coli Enterotoxin STp Antibody |
|||
abx023840-1mg | Abbexa | 1 mg | EUR 1053.6 |
E. coli O157 (9.88) Antibody |
|||
BNC040207-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against E. coli O157 (9.88),CF405S conjugate, Concentration: 0.1mg/mL |
MLT and 5-HIAA ranges within the 222 mg/kg group considerably elevated in comparison with these within the CT and CT+111 mg/kg teams. As well as, the AADC and AA-NAT gene expression ranges within the duodenum and jejunum had been elevated by the supplementation of RP 5-HTP. Rumen-protected 5-hydroxytryptophan promoted melatonin synthesis within the pineal gland and intestinal tract through the pure gentle interval.